Scarica l'app Stockscreener
73.96
16.30%
-14.40
Dopo l'orario di chiusura:
76.64
2.68
+3.62%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CORT Giù?
Forum
Previsione
Corcept Therapeutics Inc Borsa (CORT) Ultime notizie
Corcept Therapeutics (CORT) Sees Significant Drop of 13.3% - GuruFocus
Why Corcept (CORT) Shares Are Falling Today - The Globe and Mail
Corcept Therapeutics (CORT) Shares Drop as Optime Care Ends Dist - GuruFocus
Corcept Therapeutics (CORT) Adjusts Korlym Distribution Strategy - GuruFocus
How sentiment analysis helps forecast Corcept Therapeutics Incorporated2025 Retail Activity & Real-Time Volume Triggers - newser.com
Corcept Therapeutics (CORT) Shares Drop Amid Market Activity - GuruFocus
Analyzing Corcept Therapeutics Incorporated with risk reward ratio chartsQuarterly Market Summary & Community Consensus Trade Alerts - newser.com
Corcept Therapeutics (CORT) Rating Reiterated as 'Buy' by HC Wai - GuruFocus
Volume spikes in Corcept Therapeutics Incorporated stock – what they meanJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com
Corcept Therapeutics' (CORT) "Hold (C)" Rating Reiterated at Weiss Ratings - MarketBeat
Insider Sell: William Guyer Sells 20,000 Shares of Corcept Thera - GuruFocus
Platinum-Resistant Ovarian Cancer Treatment Market Sees Momentum with Next-Generation Targeted Strategies | DelveInsight - The Malaysian Reserve
Corcept Therapeutics Incorporated stock trend outlook and recovery pathWeekly Profit Recap & Daily Volume Surge Signals - newser.com
Corcept Therapeutics (NASDAQ:CORT) Stock Price Down 4.9%Here's Why - MarketBeat
Pre-ESMO insights: Corcept on platinum-resistant ovarian cancer - pharmaphorum
Corcept Therapeutics Board Member Resigns, Continues as Consultant - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT) and Genmab (GMAB) - The Globe and Mail
Corcept's NDA for its hypercortisolism treatment gets FDA nod - MSN
1 Cash-Heavy Stock with Exciting Potential and 2 That Underwhelm - The Globe and Mail
Myasthenia Gravis Pipeline Outlook Report 2025: Novel Therapeutics, Clinical Advancements, and Opportunities - The Globe and Mail
'This isn't a dress rehearsal': Why the coming months could be big for a Peninsula drug company that has survived decadesSan Francisco Business Times - The Business Journals
Truist Financial Maintains Corcept Therapeutics(CORT.US) With Buy Rating, Maintains Target Price $135 - 富途牛牛
What Fibonacci levels say about Corcept Therapeutics Incorporated reboundWeekly Risk Report & AI Forecasted Entry and Exit Points - newser.com
Will Corcept Therapeutics Incorporated bounce back from current supportQuarterly Earnings Summary & Real-Time Volume Analysis - newser.com
Is a relief rally coming for Corcept Therapeutics Incorporated holdersJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
QRG Capital Management Inc. Acquires 13,829 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Why Corcept Therapeutics Incorporated stock is seen as undervalued2025 Technical Overview & Real-Time Market Sentiment Alerts - newser.com
Visual analytics tools that track Corcept Therapeutics Incorporated performance2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
Is Corcept Therapeutics Incorporated (HTD) stock undervalued by metricsJuly 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Earnings Tell The Story For Corcept Therapeutics Incorporated (NASDAQ:CORT) As Its Stock Soars 27% - 富途牛牛
JSF Financial LLC Makes New Investment in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics (CORT): Evaluating Valuation After New Curant Health Partnership and Pipeline Progress - Yahoo Finance
Corcept Therapeutics (NASDAQ:CORT) Insider Joseph Douglas Lyon Sells 5,000 Shares - MarketBeat
Low-Volatility Stocks Underperforming: RSI, ADT, CORT AnalysisNews and Statistics - IndexBox
Here’s What Makes Corcept Therapeutics (CORT) an Attractive Investment? - Yahoo Finance
Synergy Asset Management LLC Raises Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Downgraded by Zacks Research to Strong Sell - MarketBeat
Public Employees Retirement System of Ohio Boosts Stock Holdings in Corcept Therapeutics Incorporated $CORT - Defense World
Will Corcept Therapeutics Incorporated (HTD) stock see insider accumulationJuly 2025 Update & Community Supported Trade Ideas - newser.com
Wealth Enhancement Advisory Services LLC Buys 5,693 Shares of Corcept Therapeutics Incorporated $CORT - Defense World
Why Corcept (CORT) Stock Is Trading Up Today - TradingView
Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym? - Yahoo
How moving averages guide Corcept Therapeutics Incorporated trading2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com
Curant Rare Announces Pharmacy Partnership with Corcept Therapeutics - Business Wire
Published on: 2025-10-01 03:29:23 - newser.com
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):